Geode Capital Management’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.79M | Buy |
415,607
+4,439
| +1% | +$83.2K | ﹤0.01% | 2508 |
|
|
2025
Q1 | $7.4M | Buy |
411,168
+9,117
| +2% | +$164K | ﹤0.01% | 2464 |
|
|
2024
Q4 | $6.76M | Buy |
402,051
+2,388
| +0.6% | +$40.2K | ﹤0.01% | 2591 |
|
|
2024
Q3 | $6.47M | Buy |
399,663
+8,881
| +2% | +$144K | ﹤0.01% | 2622 |
|
|
2024
Q2 | $3.21M | Buy |
390,782
+11,532
| +3% | +$94.8K | ﹤0.01% | 2952 |
|
|
2024
Q1 | $5.61M | Buy |
379,250
+9,980
| +3% | +$148K | ﹤0.01% | 2635 |
|
|
2023
Q4 | $5.36M | Buy |
369,270
+14,560
| +4% | +$211K | ﹤0.01% | 2670 |
|
|
2023
Q3 | $3.83M | Buy |
354,710
+14,005
| +4% | +$151K | ﹤0.01% | 2774 |
|
|
2023
Q2 | $4.4M | Buy |
340,705
+13,246
| +4% | +$171K | ﹤0.01% | 2756 |
|
|
2023
Q1 | $4.32M | Buy |
327,459
+12,512
| +4% | +$165K | ﹤0.01% | 2694 |
|
|
2022
Q4 | $4.72M | Buy |
314,947
+6,306
| +2% | +$94.6K | ﹤0.01% | 2698 |
|
|
2022
Q3 | $3.64M | Buy |
308,641
+1,795
| +0.6% | +$21.2K | ﹤0.01% | 2843 |
|
|
2022
Q2 | $3.47M | Buy |
306,846
+873
| +0.3% | +$9.86K | ﹤0.01% | 2895 |
|
|
2022
Q1 | $9.15M | Sell |
305,973
-5,293
| -2% | -$158K | ﹤0.01% | 2410 |
|
|
2021
Q4 | $8.25M | Buy |
311,266
+712
| +0.2% | +$18.9K | ﹤0.01% | 2585 |
|
|
2021
Q3 | $11.3M | Buy |
310,554
+12,641
| +4% | +$459K | ﹤0.01% | 2374 |
|
|
2021
Q2 | $12.9M | Buy |
297,913
+18,619
| +7% | +$808K | ﹤0.01% | 2283 |
|
|
2021
Q1 | $9.55M | Buy |
279,294
+19,263
| +7% | +$659K | ﹤0.01% | 2396 |
|
|
2020
Q4 | $9.1M | Buy |
260,031
+4,669
| +2% | +$163K | ﹤0.01% | 2239 |
|
|
2020
Q3 | $6.13M | Buy |
255,362
+5,424
| +2% | +$130K | ﹤0.01% | 2271 |
|
|
2020
Q2 | $4.57M | Buy |
249,938
+6,580
| +3% | +$120K | ﹤0.01% | 2386 |
|
|
2020
Q1 | $3.8M | Buy |
243,358
+17,432
| +8% | +$272K | ﹤0.01% | 2293 |
|
|
2019
Q4 | $4.83M | Sell |
225,926
-7,661
| -3% | -$164K | ﹤0.01% | 2477 |
|
|
2019
Q3 | $4.37M | Buy |
233,587
+2,371
| +1% | +$44.3K | ﹤0.01% | 2461 |
|
|
2019
Q2 | $6.03M | Buy |
231,216
+28,173
| +14% | +$735K | ﹤0.01% | 2276 |
|
|
2019
Q1 | $5.22M | Buy |
203,043
+10,124
| +5% | +$260K | ﹤0.01% | 2309 |
|
|
2018
Q4 | $4.44M | Buy |
192,919
+27,942
| +17% | +$643K | ﹤0.01% | 2290 |
|
|
2018
Q3 | $5.3M | Buy |
164,977
+152
| +0.1% | +$4.88K | ﹤0.01% | 2326 |
|
|
2018
Q2 | $4.66M | Buy |
164,825
+37,315
| +29% | +$1.06M | ﹤0.01% | 2362 |
|
|
2018
Q1 | $4.51M | Buy |
127,510
+2,572
| +2% | +$91K | ﹤0.01% | 2297 |
|
|
2017
Q4 | $4.85M | Buy |
124,938
+19,588
| +19% | +$760K | ﹤0.01% | 2231 |
|
|
2017
Q3 | $2.68M | Buy |
105,350
+2,213
| +2% | +$56.2K | ﹤0.01% | 2580 |
|
|
2017
Q2 | $2.82M | Buy |
103,137
+1,913
| +2% | +$52.2K | ﹤0.01% | 2531 |
|
|
2017
Q1 | $3.35M | Buy |
101,224
+25,057
| +33% | +$829K | ﹤0.01% | 2357 |
|
|
2016
Q4 | $1.81M | Sell |
76,167
-4,119
| -5% | -$98K | ﹤0.01% | 2689 |
|
|
2016
Q3 | $2.95M | Buy |
80,286
+5,491
| +7% | +$201K | ﹤0.01% | 2310 |
|
|
2016
Q2 | $1.67M | Buy |
74,795
+1,693
| +2% | +$37.7K | ﹤0.01% | 2600 |
|
|
2016
Q1 | $1.52K | Buy |
73,102
+7,532
| +11% | +$157 | ﹤0.01% | 2628 |
|
|
2015
Q4 | $1.99M | Buy |
65,570
+7,814
| +14% | +$237K | ﹤0.01% | 2497 |
|
|
2015
Q3 | $1.43M | Buy |
57,756
+2,911
| +5% | +$71.9K | ﹤0.01% | 2660 |
|
|
2015
Q2 | $1.76M | Buy |
54,845
+875
| +2% | +$28.1K | ﹤0.01% | 2583 |
|
|
2015
Q1 | $1.93M | Buy |
53,970
+8,037
| +17% | +$287K | ﹤0.01% | 2467 |
|
|
2014
Q4 | $1.04M | Buy |
45,933
+1,855
| +4% | +$42.1K | ﹤0.01% | 2815 |
|
|
2014
Q3 | $855K | Buy |
44,078
+343
| +0.8% | +$6.65K | ﹤0.01% | 2869 |
|
|
2014
Q2 | $1.59M | Buy |
43,735
+368
| +0.8% | +$13.4K | ﹤0.01% | 2525 |
|
|
2014
Q1 | $1.68M | Buy |
43,367
+1,437
| +3% | +$55.7K | ﹤0.01% | 2441 |
|
|
2013
Q4 | $1.2M | Buy |
41,930
+456
| +1% | +$13K | ﹤0.01% | 2608 |
|
|
2013
Q3 | $1.49M | Buy |
41,474
+5,944
| +17% | +$213K | ﹤0.01% | 2352 |
|
|
2013
Q2 | $1.19M | Buy |
+35,530
| New | +$1.19M | ﹤0.01% | 2369 |
|